Diagnoplex's Series A Round

Diagnoplex raised a round of funding on December 12, 2008.

Diagnoplex is leveraging its molecular platform capabilities to develop a colorectal cancer (CRC) screening test. Diagnoplex's lead product, Colox, is a convenient and minimally-invasive blood test de…

Articles about Diagnoplex's Series A Round: